Brinker Capital Investments, LLC Atri Cure, Inc. Transaction History

Brinker Capital Investments, LLC

$11.4 Billion
Q3 2025

A detailed history of Brinker Capital Investments, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 61,478 shares of ATRC stock, worth $2.02 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

61,478

Previous 63,601 3.34%

Holding current value

$2.02 Million

Previous $2.08 Million 3.98%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$29.24 - $37.87 $62,076 - $80,398	-2,123 Reduced 3.34%	61,478 $2.17 Million
Q2 2025 Aug 14, 2025	SELL	$29.07 - $34.94 $3,052 - $3,668	-105 Reduced 0.16%	63,601 $2.08 Million
Q1 2025 Jul 31, 2025	BUY	$30.4 - $42.4 $581,308 - $810,772	19,122 Added 42.89%	63,706 $2.06 Million
Q4 2024 Jul 31, 2025	BUY	$27.02 - $38.2 $107,080 - $151,386	3,963 Added 9.76%	44,584 $1.36 Million
Q3 2024 Jul 31, 2025	SELL	$20.34 - $29.5 $830,461 - $1.2 Million	-40,829 Reduced 50.13%	40,621 $1.14 Million

Q2 2024 Jul 31, 2025	BUY	$19.86 - $29.09 $264,713 - $387,740	13,329 Added 19.57%	81,450 $1.85 Million
Q1 2024 Jul 31, 2025	BUY	$28.21 - $37.78 $405,095 - $542,520	14,360 Added 26.71%	68,121 $2.07 Million
Q4 2023 Jul 31, 2025	SELL	$32.99 - $43.25 $573,795 - $752,247	-17,393 Reduced 24.44%	53,761 $1.92 Million
Q3 2023 Jul 31, 2025	SELL	$41.12 - $57.73 $156,584 - $219,835	-3,808 Reduced 5.08%	71,154 $3.12 Million
Q2 2023 Jul 31, 2025	SELL	$40.44 - $49.6 $194,395 - $238,427	-4,807 Reduced 6.03%	74,962 $3.7 Million
Q1 2023 Jul 31, 2025	BUY	$35.87 - $47.22 $485,464 - $639,075	13,534 Added 20.43%	79,769 $3.31 Million
Q4 2022 Feb 06, 2023	SELL	$33.48 - $47.45 $195,623 - $277,250	-5,843 Reduced 8.11%	66,235 $2.94 Million
Q3 2022 Nov 01, 2022	BUY	$38.25 - $52.62 $539,707 - $742,468	14,110 Added 24.34%	72,078 $2.82 Million
Q2 2022 Jul 18, 2022	SELL	$35.1 - $66.01 $1.12 Million - $2.1 Million	-31,865 Reduced 35.47%	57,968 $2.37 Million
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $185,039 - $230,018	-3,222 Reduced 3.46%	89,833 $5.9 Million
Q4 2021 Feb 08, 2022	SELL	$63.4 - $87.14 $521,782 - $717,162	-8,230 Reduced 8.13%	93,055 $6.47 Million
Q2 2021 Aug 03, 2021	BUY	$64.13 - $80.18 $5 Million - $6.25 Million	78,004 Added 335.05%	101,285 $8.04 Million
Q1 2021 May 12, 2021	SELL	$53.79 - $66.98 $1.07 Million - $1.33 Million	-19,847 Reduced 46.02%	23,281 $1.53 Million
Q4 2020 Feb 16, 2021	BUY	$34.56 - $57.55 $1.07 Million - $1.79 Million	31,100 Added 258.56%	43,128 $2.4 Million
Q3 2020 Dec 03, 2020	BUY	$38.36 - $46.91 $461,394 - $564,233	12,028 New	12,028 $480,000

Others Institutions Holding ATRC

# of Institutions

243

Shares Held

50.9M

Call Options Held

27.1K

Put Options Held

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.53B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Account

Brinker Capital Investments, LLC Atri Cure, Inc. Transaction History